Skip to main content

Depth of Anesthesia (DOA)

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

NeuroWave Systems
NeuroWave SystemsOH - Beachwood
1 program
Propofol induction followed by randomized doses of desfluraneN/A1 trial
Active Trials
NCT02088671Completed76Est. Oct 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
NeuroWave SystemsPropofol induction followed by randomized doses of desflurane

Clinical Trials (1)

Total enrollment: 76 patients across 1 trials

NCT02088671NeuroWave SystemsPropofol induction followed by randomized doses of desflurane

Effectiveness of the NeuroSENSE for Monitoring the Hypnotic Depth of Anesthesia

Start: Jun 2014Est. completion: Oct 201676 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.